As Australia’s first and largest specialist hospital for women and newborns, the Women’s is ideally placed to lead national and international clinical trials.
It is through our program of clinical trials that the Women’s is constantly improving health outcomes for women and babies.
- HIPSTER: Breathing support for premature infants
- Immunity and ovarian cancer
- VIVIANE: Evaluation of the efficacy of the HPV vaccine
- WHAM: Women’s Health After Surgical Menopause
- BEAR: Building Early Attachment Resilience
- PeriCoach: System-assisted pelvic floor exercises
- DAME: Diabetes and Antenatal Milk Expressing
- Prone position in preeclampsia
- FLAMINGO: Assessing use of a lactate test to help reduce caesarean sections
The fact the Women’s is a large specialist public hospital is an enviable strength of our innovative research program, ideally positioning us to recruit participants to our clinical trials.
We annually conduct in excess of 60 clinical trials involving more than 3000 participants and produce almost 300 publications.
Our clinical trials are conducted across our key research areas of newborn health, infectious diseases, gynaecology, women’s cancer, pregnancy, mental health, midwifery, allied health, anaesthetics and family violence prevention.
Clinical trials at the Women’s include the testing of new cancer treatments, vaccines, surgical and other medical treatments, medical devices and behavioural therapies.
We are always extremely grateful to the women, babies and families who participate in our clinical trials. It is they who make this important research possible and make such an invaluable contribution to improved healthcare for so many others, now and in years to come.
HIPSTER: Breathing support for premature infants
HIPSTER is an international, multi-centre, clinical trial led by the Women’s Newborn Research Group and conducted in units in Australia and Norway. The trial compared two types of breathing support for premature infants.Learn more
Immunity and ovarian cancer
This clinical trial sought to identify changes in the immune system of women diagnosed with ovarian cancer. Such changes may be helpful in diagnosis, in assessing response to treatment and in identifying when and if the cancer might come back.Learn more
VIVIANE: Evaluation of the efficacy of the HPV vaccine
VIVIANE is evaluating the efficacy of the human papillomavirus vaccine (HPV) in healthy adult women aged 26 years and older.Learn more
WHAM: Women’s Health After Surgical Menopause
WHAM is providing new evidence to inform decision making around surgical menopause for high risk women and those considering oophorectomy for other indications.Learn more
BEAR: Building Early Attachment Resilience
BEAR is providing early intervention for mothers and infants aged two to 12 months who are at risk of attachment and related developmental problems.Learn more
PeriCoach: System-assisted pelvic floor exercises
PeriCoach® offers system-assisted pelvic floor exercises in the management of female stress urinary incontinence.Learn more
DAME: Diabetes and Antenatal Milk Expressing
DAME is exploring the benefits of antenatal milk expressing, by mums with diabetes in pregnancy.Learn more
Prone position in preeclampsia
This trial is testing whether placing pregnant women in the prone position helps to reduce blood pressure in those with preeclampsia and if it improves comfort.Learn more
FLAMINGO: Assessing use of a lactate test to help reduce caesarean sections
FLAMINGO is assessing if fetal scalp-blood lactate measurements can reduce caesarean sections during labour.Learn more